Abbott has the leading market share of CGMs and insulin pens in North America, as per the same analysis by GlobalData. In Q1 ...

t:slim X2, meanwhile, is powered by Control-IQ+ technology. Tandem designed the advanced hybrid closed-loop automated insulin ...

Abbott analysis finds FreeStyle Libre CGM and GLP-1 drug adherence rise when used together. By Andrea Park Sep 29, 2023 10:24am. Abbott continuous glucose monitor Freestyle ...

FreeStyle Libre 2 has a 1-hour warmup period before it starts generating glucose data. That’s a full hour shorter than the competing Dexcom G6. Optional alerts.

Abbott Laboratories ABT recently announced that the FreeStyle Libre 2 system's reimbursement coverage has been expanded by the French health authority to cover individuals using basal insulin as ...

Abbott’s FreeStyle Libre glucose sensor has already been proven to help people with both Type 1 and Type 2 diabetes better manage their blood sugar levels, and a new study demonstrates just how ...

The Abbott FreeStyle Libre 2 can be used as a real-time continuous glucose monitor (CGM) with an upgrade to the FreeStyle LibreLink app. Please note, the below information comes with a critical update ...

In Q1 2024, Abbott's FreeStyle Libre sales grew 25.5% to reach $1.5bn. The Plus version is gradually replacing the older FreeStyle Libre 2 sensor across many markets.

Merit Medical has gained 58.1% compared with the industry’s 17.9% rise in the past year. Boston Scientific, carrying a Zacks Rank #2 at present, has an estimated long-term growth rate of 11.5%.